Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors
| Image |  |
|---|---|
| Description | scientific article published on 26 October 2012 |
| Author/s |
author: Jean-Yves Blay Jean-Charles Soria |
| Publication date | October 26, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |